HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Tag: high risk patient
-
NEW COVID TREATMENT IN INDIA: ANTIBODY COCKTAIL BY ROCHE AND CIPLA
The monoclonal antibody cocktail, effective against the B.1.617 variant (found in India) is being imported by Roche, a Switzerland-based leading healthcare company and marketed in India through Cipla Ltd has…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila